1. Lemmon, M. A., and J. Schlessinger. 2010. Cell signaling by receptor
tyrosine kinases. Cell. 141:1117–1134.
17. Shi, F., S. E. Telesco, ., M. A. Lemmon. 2010. ErbB3/HER3
intracellular domain is competent to bind ATP and catalyze
autophosphorylation. Proc. Natl. Acad. Sci. U S A. 107:7692–
7697.
2. Oda, K., Y. Matsuoka, ., H. Kitano. 2005. A comprehensive pathway
map of epidermal growth factor receptor signaling. Mol. Syst. Biol.
1:2005.0010.
18. Olayioye, M. A. 2000. New EMBO members’ review: the ErbB
signaling network: receptor heterodimerization in development and
cancer. EMBO J. 19:3159–3167.
3. Gschwind, A., O. M. Fischer, and A. Ullrich. 2004. The discovery of
receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer.
4:361–370.
19. Van Lengerich, B., C. Agnew, ., N. Jura. 2017. EGF and NRG
induce phosphorylation of HER3/ERBB3 by EGFR using distinct
oligomeric mechanisms. Proc. Natl. Acad. Sci. U S A.
114:E2836–E2845.
20. Nagashima, T., H. Shimodaira, ., M. Hatakeyama. 2006. Quantitative
transcriptional control of ErbB receptor signaling undergoes graded to
biphasic response for cell differentiation. J. Biol. Chem. 282:4045–
4056.
4. Lemmon, M. A., J. Schlessinger, and K. M. Ferguson. 2014. The EGFR
family: not so prototypical receptor tyrosine kinases. Cold Spring
Harb. Perspect. Biol. 6:a020768.
5. Citri, A., and Y. Yarden. 2006. EGF-ERBB signalling: towards the systems level. Nat. Rev. Mol. Cell Biol. 7:505–516.
6. Red Brewer, M., S. H. Choi, ., G. Carpenter. 2009. The juxtamembrane region of the EGF receptor functions as an activation domain.
Mol. Cell. 34:641–651.
7. Yarden, Y., and M. X. Sliwkowski. 2001. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2:127–137.
8. Scaltriti, M., and J. Baselga. 2006. The epidermal growth factor receptor
pathway: a model for targeted therapy. Clin. Cancer Res. 12:5268–5272.
9. Alroy, I., and Y. Yarden. 1997. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial
ligand-receptor interactions. FEBS Lett. 410:83–86.
10. Liu, P., T. Sudhaharan, ., T. Wohland. 2007. Investigation of the
dimerization of proteins from the epidermal growth factor receptor
family by single wavelength fluorescence cross-correlation spectroscopy. Biophys. J. 93:684–698.
11. Samaras, P., T. Schmidt, ., M. Wilhelm. 2020. ProteomicsDB: a
multi-omics and multi-organism resource for life science research.
Nucleic Acids Res. 48:D1153–D1163.
12. Schmidt, T., P. Samaras, ., M. Wilhelm. 2018. ProteomicsDB.
Nucleic Acids Res. 46:D1271–D1281.
13. Wilhelm, M., J. Schlegl, ., B. Kuster. 2014. Mass-spectrometry-based
draft of the human proteome. Nature. 509:582–587.
480 Biophysical Journal 121, 470–480, February 1, 2022
21. Nagashima, T., H. Shimodaira, ., M. Hatakeyama. 2007. Quantitative
transcriptional control of ErbB receptor signaling undergoes graded to
biphasic response for cell differentiation. J. Biol. Chem. 282:4045–
4056.
22. Fabricant, R. N., J. E. De Larco, and G. J. Todaro. 1977. Nerve growth
factor receptors on human melanoma cells in culture. Proc. Natl. Acad.
Sci. U S A. 74:565–569.
23. Jeong, H., J. Kim, ., A. Kim. 2014. Neuregulin-1 induces cancer stem
cell characteristics in breast cancer cell lines. Oncol. Rep. 32:1218–
1224.
24. Shankaran, H., H. S. Wiley, and H. Resat. 2006. Modeling the effects of
HER/ErbB1-3 coexpression on receptor dimerization and biological
response. Biophys. J. 90:3993–4009.
25. Shankaran, H., Y. Zhang, ., H. Resat. 2008. Quantifying the effects of co-expressing EGFR and HER2 on HER activation and
trafficking. Biochem. Biophys. Res. Commun. 371:220–224.
26. Mac Gabhann, F., and A. S. Popel. 2007. Dimerization of VEGF receptors and implications for signal transduction: a computational study.
Biophys. Chem. 128:125–139.
27. Kholodenko, B. N., O. V. Demin, ., J. B. Hoek. 1999. Quantification
of short term signaling by the epidermal growth factor receptor. J. Biol.
Chem. 274:30169–30181.
...
論文の公開元へ
